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Primary human dermal cell suspensions prepared 
from the papillary dermis of keratomed skin strips 
were used to investigate the effect of indigenous 
derlDal macrophages (HLA-DR+, CDl1c+ CDl1b+ 
CDlc - phagolysosome +) upon dermal fibroblast pro-
liferation. Rapid derlDal fibroblast expansion was 
induced upon immunomagnetic bead removal of 
CDllb+ or CDllc+ cells as well as by removal of 
more inclusive subsets contained within the DR + 
population, but the removal of mast cells, endothe-
lial cells, and CDlc + derlDal Langerhans cells from 
dermal cell suspensions failed to result in prolifera-
tion of the relDaining cell subsets. Removal oflBIO+ 
fibroblasts from macrophage depleted (CDl1b -) der-
mal cell suspensions essentially abrogated the unre-
strained proliferation of the CDl1b - dermal cells. 
Flow cytometric cell cycle analysis of cultured mac-
rophage-depleted dermal cells confirmed that the 
unrestrained proliferating cells contain procollagen 
I n normal . human dermis , endot,helial cells and m eSenCh,Y-mally derived celis, such as fibroblasts and other stromal dendrocytes, coexist with bone marrow-derived mast cells, dermal Langerhans cells, ma crophages, and T cells [1-8]. Macrophages can play an important role in the regulation of 
cell growth of certain non hemopoietic cells [9,10] . T he regulatory 
effect has been primarily related to the secretory capacity of 
macrophages [11,12]. During certain inflammatory conditions, 
tissue m acrophages and infiltrating blood monocytes have been 
associated with moqification of fibroblast function such as collagen 
synthes is [10,13-15]. An appropriate balance of monocyte/macro-
phage growth-regulatory cytokines also plays an important role in 
th e contro l of passaged fibroblast cell growth [15 ,16]. Interl eukin-1 
(IL-l) is a majo r mo nocyte/macrophage product which is growth 
stimulating for passaged fibroblasts [17] . Fibroblast inhibitory fac-
tors produced by activated blood monocytes and inflammatory 
peritoneal m acrophages have been reported [18-20] and include 
interferon- (\' and -{3 [15]. Similarly, a complex relationship exists 
between alveolar macrophages and lung fibrob lasts, with both 
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1+ as well as pro collagen 1- dermal fibroblasts. Inhi-
bition of primary fibroblast expansion by adding a 
supernatant from unfractionated derlDal cells sug-
gested that a growth-inhibitory soluble activity of 
>30,000 kDa dominates the cytokine mixture re-
leased by unfractionated fresh dermal cells ex V;II0. 
Inhibitory · activity counterbalanced positive fibro-
blast growth-stimulatory cytokines released by der-
m.al cells because neutralizing antibodies to insulin-
like growth factor I and interleukin-l{3 resulted in 
decreased CDllb - dermal cell fibroblast prolifera-
tion. These data indicate an important role for der-
mal macrophages of the DR+ CDllb+ CDl1c+ 
CDlc - phenotype in the normal homeostatic re-
straint of primary human dermal fibroblast prolifer-
ation. Key IVords: dermal Lallgerilalls celllfloIV cytoll1.et~l'/ 
gl'OIVt/1 illi,U,itioll/C)'tokilles. ] IlIvest D el'1llatol 106:305-311, 
1996 
posltlve and negative interactions repo rted [1 0,21] . T he homeo-
static m echanisms among m acrophages of nonnal skin w ith various 
constitutive stromal cell s of human dermis , however, is presently 
unknown . 
Fibroblasts ha ve been implica ted in several skin diseases, such as 
psoriasis [22] and scleroderma [23]. O ur findin gs that primary ex 
lIil'O dermal fibrobla st fun ction can be altered by dermal cells of the 
m onocyte/m acrophage seri es indica tes that resident derm al m acro-
phages constitu tively act to res train the growth of de rmal fi bro-
blasts. 
MATEIU ALS AND METH ODS 
Subjects N o rmal 6 -111111 punch biopsies and keratomes from the buttock 
and right hip . respectively. w ere obtained under aseptic conditions from '12 
hea lthy volunteers. T he age of volunteers ranged between 20 to 40 y. 
In fo rmed consent was obtained fro III all volunteers. in accordance with 
loca l Institutional. Re view Board approval. 
Antibodies Used for Dermal Cell Staining, Flow Cytometric Anal-
ysis, Neutralizing, and Depletions O KMl (American Type C ul ture 
Collection. Rockville . MD) reacts with th e CD11b m olecule on macro-
phages. A murine m onoclo nal antibody to the HLA- DR. molecule was 
obtained from Becton- D ickinson (Mountain View, CAl . LeuM 5 (Becton-
Dickinson) recognizes the CD ll c molecule on m acrophages. Anti CD l c 
(A MAC, Inc. ) recogni zes the CD l c molecule present on thymocytes. 0 11 a 
subpopulation of 13 lymphocytes, and on Langerhans and dendritic cell s. 
181 0 (kindly provided by Dr. Kay Singer. D uke University) reacts w ith 
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fibrob lasts , monocytes, and macrophages. A pro-co llagen type I monoclo-
nal antibody (SP1.D8) that binds to an intracellular pro-coll agen molecule 
in fibrob lasts was obtained frolll the Developmental Studies Hybridoma 
Bank (ma.intained by the Department of Pharmacology and Molecular 
Sciences. Johns Hopkins University School of Medicine, Baltimore. MD. 
and the Department of Biology. University of Iowa, Iowa C ity, lA, under 
Contract N01-HD-6-2915 from NICHD). 
Neutrali zing murine monoclon;1I antibodies to 11-1 c< and 11-1 {3 we re 
provided by Dr. Alln Berger of Upjohn Llboratories (Kabmazoo, MI). A 
murine monoclonal antibody that neutralizes insulin-li ke growth f.1Ctor 1 
(IGF-l) was kindly provided by Dr. Amir Tavakkol (Department of 
Dermatology, University of Michigan). 
Dertnal Cell Depletions Dermal ce ll suspensions prepared as previ-
ously descl·ibcd 14] were incubated in separate tubes with monoclona l 
antibodies aga inst either CDllb (ascites. 1:50), CO Il e (1 J.Lg/ml) , H1A DR. 
(I J.Lg/ml), CDl c (1 J.Lg/ ml) , and IBI0 (ascites, 1:400) for 45 min at 4°C. 
Antibod ies were diluted appropriately in 1 'X, feta l bovine serum in RPMI, 
and then 200 J.LI of an tibody dilution was added to 0. 5 X 106 cell s. After the 
incubation period, cells were washed three times with I 'Yr, fetal bovine 
serum in phosphate-buffe red sa line. Antibody-treated cell s were incubated 
either with magnetic beads o r with complement. Derma l ce lls exposed to 
murine monoclonal an tibodies to CDll b, COIl c, HLA DR., and C Ol c 
were incubated with magnetic beads coated with goat anti-mouse IgG 
(Dynabeads M-450 Dyna\, Oslo, Norway) fo r 45 min at 4°C. Cell s were 
washed by placing them twice against a vertica l magnet for 5 min at room 
temperature , and the supernatant containing the negatively selected ce lls 
was co ll ected. 
1 Bl O-treated cell s were incubated with rabbit complement (Ccdarlane, 
Hornby, Ontario, Canada) for 1 h at 37"C. Cell s were washed three ti mes 
with phosphate-buff-e red sa line as described above. 
Dermal ce lls (1 .5-5 X 104 cells/per well ) were plated in 96-well 
Aat-bottom microtiter plates. in tripli cates. Cell s we re incubated for 7 d in 
5%, CO2 95'!I\, air at 37"C. and pulsed with 1 J.LC i of [' I-i"I-TdR. for the last 
18 h of culture. 
Lactate Dehydrogenase Assay Derm,Il cell s were depleted ofCDll b + 
cell s as described above using lmmullomagnetic beads. T he un fra ctionated 
denn,,1 ceBs, CD U b- ce ll s, and CD11 b " cell s were ClI ltured for 24 and 96 
h , after which culture supernatants were harvested ,md cell Iysates prepared 
in '1 ";" Tritoll X 'I 00. Lactate dehydrogenase (LDH) activity was Illeasured ill 
these samples by use of a co lorimetric k.it (Sigma Chem ical Co .. St. Louis, 
MO). The percentage of LDH released equa led the amount rel eased divided 
by the amount released plus the amoun t present in cell lysates. 
Dermal Cell Supernatant Fractionation Determination of the ap-
proximate molecular weight of the molecule(s) responsible for restrain.ing;1I 
II ;l ro fibrobla st proliferation was accomplished by fractionation of the dermal 
cell supernatants w ith Amicon Cell tricon centrifugal concentrators (Ami-
con, Inc. , Beverly. MA) . Supernatant of tota l dermal cell s cultured for 48 h 
were fj,actionated with Centri con- 'IO (10.000 MW cut-oft) alld Centri-
con-3~ (30,OOD MW cut-off). Three fractions were o btained: < 10 kDn. 
between 10-30 kDa and > 30 kDa. C Dt1b- derma l ce lls were incubated in 
triplicates with either lOO J.LI of each fraction (reconstituted to o riginal 
supernatant vo lume) , and 100 J.LI of ullti'actionatcd supernatant as a control. 
Cell s were then cultured for 7 d and pulsed with 1 J.LCi ofL' I-I.1-TdR for the 
last 18 h of cu lture. 
Neutralizing Antibody Assay In an attempt to identify the positive 
regulatory factors associ;ned with fibrob last expans ion in macrophage-
depleted dermal cell suspensions. COIl b- dermal cell s were incubated with 
neutralizing antibod ies to IL-l {3, IL-I (Y, and IGF-1 for 2 h at 37°C. 
Pro liferation was determined by adding 1 J.LCi of I' H]-TdR. to each well 
over the last 18 h of a 7-d culture. 
Electron Microscopy Dermal cell suspensions were incubated with 
anti-CD1lb ascites (1 :50 dilution) for 45 min at 4°C. Antibody-treated ce ll s 
we re incubated with magnetic beads coa ted with goat anti- mouse IgG for 
45 min at 4°C in a rotator (DYl1al Inc .. Fort Lee, NJ) . The beads with the 
C OlI b + attached cells were collected usillg a verti cal Illagllet (Biol11ag: 
Advan ced M:lglle ti cs, Inc .. Cambridge, MA) and processed for electron 
microscopy as previo usly described 124]. 
Flow Cytometry Fresh and cultured derma l ce ll suspell siom we[e 
trip le-stained w ith murine monoclonal antibodies to C Dllb (lgG2 b), 
biotin-HLA-DH.. (lgG2a) , and COl c ( lgG l) , essentiall y as previously 
described [4 J. Dete rmination of the presence of cytoplasmi c pro-
collagen I"' fibrobla sts in C D 'I 'I b- derma l ce ll s was ve ri fied by staining 
ethanol-permeabilized ce ll s 125] with a Illurin e monoclonal antibody 
against pro-coll"gen type I (lgG I) and Auoresce in isothiocyanatc 
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Figure 1. Co-staining of dertnal cells for HLA DR. CDllb. and 
CDle reveals CDllb+ dermal cell subpopulations. A, B) Dermal ceUS 
were stained for APC HLA DR (A and B, y axis) and PE mouse IgG2b 
isotype (A . . " axis) o r PE CD11 b (B. x a".i s). C,D) Dermal cell s were stained 
for PE CD,! 'I b (C, )' axis) and FITC mouse IgG I isotype (C, x a"i s) or FITe 
C D'I c (D. x axjs). 
(FITC)-conjuga ted goat anti-mouse IgG l. The ce Ll cyc le status of these 
ce ll s was determin ed by staining with propidium iod ide. Flow cytometric 
alla lys is wa s performed using an Epi cs Elite Flow cytometer (coulter 
Cytometry , Hialeah. FL). Fluorescence da ta was analyzed using Coulter 
Elite software, and Multicycl c so ftware from Phoenix Flow Systems was 
used for ce ll cycle anal ys is. as previously descr ibed 125J. 
RESULTS 
Heterogeneous Composition ofHLA-DR + CDllb+ Dermal 
Cells Flow cytometric ana lys is of normal dermal cell suspensions 
WaS pe rfo rm ed by simu ltaneously stain in g biotin-conjugat.ed HLA 
DR I- cell s with APC- streptavidin , CD llb + cell s with PE- conju-
gated goat anti-mouse IgG2b and CDl c + ce lJ s with FITC-conju-
gated goat anti mouse IgGI (Fig 1). Mouse 19G1 and IgG2b 
isotypes were use d as control s (Fig lA,q. Among total de rmal 
cell s, 2S'Yo expressed HLA DR as dete rmined by the number of cell 
conta ine d in th e uppe r cl uster (Fig lA), as compared to the 
biotinylated IgG2a control (not shown) . Substitution of IgG2b 
isotype contro l antibody with anti COl t b, a macrophage in tegrin , 
resul ted in a shift of th e majority of HLA DR expressing cells from 
qlladmllf 1 in Palle! A to qlladmll f 2 in Pallcl B. T h ese data indicate 
that all COll b + cell s expressed HLA-DR, although a small subset 
of low intensity HLA- DR + cells was CDllb- (no rightward shift 
of cell s in qlladrnllf 1 of Pallel B). 
At least two populations were observed within the CDll b + 
derma l cell s: CDll b hi ce LI s and CD1l b"'id cell s (Palle! C, qlladrallf 
1) . Substitu tion of FITC-v isuali zed IgGl isotype control antibody 
w ith anti CDl c (Pnlle! D) shifted the CD11 b hi population to the 
right, with minimal change in position of the CDllb"';" population. 
T h ese data indicate that the DR + CDltb + population can be 
divided into CDllb l ,; COlc+ dermal Langerhans cells (Pallel D, 
qlladmllt 2) and CDll b"'id CDlc- d ermal macrophages (Pallci D, 
Ijll odrn 11 I 1) . A sma lle r , less well-defined CDllb l<) population also 
appears to be CDlc- . 
U ltrastructura l characte ri stics of the CDll b + popu lations w ere 
defined u sing CDll b + cells positively se lected from dermal cell 
su spensions with immunomagnetic beads coated with goat anti-
mouse 19G. Again, two major types of cells were observed: cells 
with an activ e cytoplasm and dense p h agolysosom es ch arac teristic 
of de rma l macrophages (Fig 2, lOp), and cells with indented nuclei 
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an d dense in termediate fiJam ents but lackin g phagolysom es and 
Birbeck gran ules, characte ri stic of cell s of dendritic APC/dermal 
Langerhans cell s/ in dete rmina te cell l.ineage (Fig 2, /"'1(0111). T he 
l.atter likely represents the CDl c+ indetermin ate cell population 
[26], w hich con ta illS the potent an tigen presentin g activity of 
normal hum an dermi s 141-
HLA-DR + CDl1 b + Macrophages Restrain Dermal Cell 
Proliferation To determine w hether d e rm al le uk ocytes reg-
ula.te the g rowth of othe r dermal cell constitu en ts, cell depi ctio n 
studies were performed. De rmal cell suspensio ns were in c ubated 
initia lly w ith anti class II major hi stocompatibili ty complex 
(MHC) (HLA-D.R.) antibody, and anti DR-tagged ce lls we re 
Figure 2. CDltb + dermal cells include two major popula-
tions: dermal macrophages an d indeterminate cells. Dermal 
cell suspensions were incubated wit.h CD I I b MoAb. Positive ce lls 
\VC [C se1ected lI sing 1111t11l.1J101nab'11ctic beads and cX31nill cd by cl.cc-
troll microscop)'. O lle cell type ill the preparation (rop) represents" 
derma l m'icrophage with a dellse cytoplasm packed with l11elano-
sorncs (solid strai{l"l al'nlJ") and acrivc lysosot11CS (opell [HIved arro",). 
T he other type ot' cel l (bot/olll) has characteristics of all indeterminate 
ce ll. Srn/I? /JII,., 2 I-tln . 
d ep leted with goat anti-mouse !gG coated immunomagnetic 
beads. T h ym idin e in co rporation by proli ferating cell s over the 
last 18 h of a 7-d cul tLlre period showed a ll in crease in 
proliferation afte r rem oval ofHLA-DR + cell s (7952 ::!:: 746 cp m) 
relat.ive to isotype contro l an tibody-treated ce ll s (4964 ± 1 467 
cp m) o r un fi'actionated, untreated dermal cell s (1l:)99 ± 382 
cp m ) (not show n). Simil arly, removal of either CD 11 b I cell s 
(42,360 ::!:: 9,280), o r CD l 1c + ce lls (46,344 ::!:: 4,608) re leased 
proliferation relative to th e !gG isotype co ntrol (21 ,600 ± 680) 
(Fig 3A). By co n trast, no such in c rease in pro liferatioll occurred 
after re m ova l of CDl c + cell s (11,802 ± 1,118), as compared to 
fgGl contro ls ( 13,483 ± 3.942) (Fig 3B), in dicati ng thar the 
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Figure 3. Dermal macrophages but not dermal Langerhans cells 
restrain dermal cell spontaneous proliferation. JI) Proliferation of 
mouse IgG2b isotype cOlltrol plus il11l11ullomagnetic bead-trea ted dermal 
ce ll s (lift "nr). Proli fe ration of anti CD1 ·, b plus il11lllullomagnetic bead and 
anti-CD1 ·1 c plus illll11u nomagnetic bead-treated dermal cell s (Illiddle and 
rig/II (lnrs, respectively). B) Proliferation of mouse IgGl isotype control plus 
il11mul1om"gllctic bead and anti-COl c plus imlllunomagnetic bead-treated 
dermal ce ll s (/t:/i and righ, b"rs, respectively). Proliferation was detcrmi.ned 
by r·' H]-TdR ill corporation for 18 h after 7 d of culture. Mean ::': SO of 
triplicates . 
re lease of pro liferat ion was not due to the d erm al Lan gerh an s 
ce ll component of DR + CD 11 b + dermal ce ll s [3,4]. 
To determine w hethe r toxic products inhibi tory to fibrob last 
prolife ration might be released by dying macrophage and dendriti c 
ce ll populations, release of n ormall y intrace llular LDB into the 
medium was determined. LDB release was highest in the l.II1frac-
tionated dermal cell medium and about 20% lower in the de rmal 
cell cultures de pleted of CDl l b -,- cells (Fig 4). Even lower LDB 
release w as observed in the CDll b + cell popu lation . T his suggests 
that within the first 24 h of dermal cell culture , a subpopulation of 
CDll b - cell s is dying due to the presence ofCDllb + cells but this 
can not be attributed to death of COlI b + cells th emselves . LDH 
rel ease in the unfi-actionated derm al cell culture decreased from 
79% at 24 h to 51 'X, at 96 h probably du e to an initial cell di e- off 
w ithin the fi rst 24 h fo ll owed by degradation of th e LDH released 
by th ese ce lls. T h e proliferative response of these un fractio nated 
dermal ce lls after 7 d of culture was lowe r (10955 ± 1172) than that 
of the derma l cells deple ted of COl t b -I- dermal m:lcrophages 
(19571 ± 1793). T his inc rease in proliferation upon removal of 
CDt l b -I- ce ll s may be due in part to the increased cell death of 
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Figure 4. Increased celJ death in early derlTIal cell cultures is due to 
the presence of CDllb + cells . Dermal cells were fractionated by 
treatme/lt with a.ll ti C D11 b pJus ill1ll1unoll1agnetic beads and cultured for 24 
h. LDI-I releasc by un fractionated dermal cells (TOT Jl L DC; _) , dermal 
cell s depleted of C Dll b+ ce ll s (CDJ "/IJ- D C ; ~). and con b + dermal cells 
(C O l 11,+ D C: 0 ). 
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Figure 5. Macrophage-depleted dermal cell expansion is lB10+ 
fibroblast-dependent. Lift) Proliferation of unfra ctionated (complcment-
trea ted alone) dem,"1 ceLi s. Middle) Proli fe ration of anti C Dll b plus 
complement treated dermal cclls. Righi) Anti-1B10 and anti-C.Dllb pili 
complcment-treated dennal cells proliferative results. Proliferation \\"a 
expressed as [' H]-TdR uptake fo r 18 h after 7 d of culture. Mean ::': SD of 
triplicates . 
COlt b - dermal cells caused by dermal macrophages within the 
fIrst 24 h of cu lture of the un fra c tionated dermal cell culture. 
Fibroblast Proliferation After Removal of CD11b + Macro-
phages C u ltured macrophage-deple ted dermal cells were exam-
ined under phase microscopy after 7 d. Cells dominating the culture 
closely resembled cultured fibroblasts, whereas viable ce lls and 
fibroblasts were o n ly rarely observed in un fractionated primary 
dermal cell cultures at this tim e (eventually fi broblast cultures do 
become established from these derma l cell cultures as they do in 
skin explants). Remova l of fibroblasts from CD11b - dermal cell 
su spen sions using lE10 monoclonal antibody [27] plus complement 
lysis markedly reduced the proliferation observed upo n removal of 
CDll b + expressing macrophages fi:om 4,140 ± 684 to 345 2: 11 8 
(Fig 5), further con fIrming the fIbro blastic n ature of the cell s. 
In o rder to quantitate w hich fibrob last subsets [28] are involved 
in th e proliferation, CD11b - - deple ted de rmal cell s o r nondepleted 
dermal cell s (unfi:actio nated DC) w ere in cubated for 7 d, harvested, 
and fixed in 70";;, e than o l. Ethano l-fixed dermal cells were incu-
bated w ith anti procollagen type J monoclonal antibody for 45 min 
fo ll owed by a FlTC-conjugated 19G 1 second antibody incubation. 
Cell cycle status was determined by stain in g with propidium iodide. 
T he results showed that, with in the llnfractionated de rmal cell 
population containing CD1l b -I- macrophages, n o procollagen 
I-stained cells were o bserved (Fig 6C)- Within the m acrophage-
depleted dermal cells, 6_7% of the total population expressed 
pro-collagen type I (Fig 6B, qlladrallis 1 alld 2) and 31':1., of these 
were in S/G 2 / M phase of the cell cycle (Fig 6B, qlladrall! 2). This 
compares with 17'Yo of the procollagen 1- cells w hich are in 
S/G2 /M, indicating selective growth of procolJagen 1-1- ce lls. T hese 
results show that th e procollagen I -I- fibroblast sub set is involved ill 
the o utg rowth that occ urs as a resu lt of macrop hage removal frolll 
dermal cells, but that they do not account for a ll proliferating cells 
(Fig 6B, qlladrall! 4) . 
Dermal Cell Inhibition of Fibroblast Proliferation by a 
Soluble Factor(s) Studies on the efFect of cytokin es produced 
by activated inflammatory macrophages on the growth of multiply 
passaged ;11 1I;lro fibroblasts has shown that in terfe ro n-a o r tumor 
necrosis factor-a (plus IL-1 a) inhibit fibro blast proliferation 
[·10 ,15] . However, consti tutive hum an dermal macrophage regula-
tion of primary fibroblast growth has not been examined . In order 
to understand the m ech anism(s) mediating fibroblast g rowth in our 
system , CDl1 b - dermal cell s w ere cultured in the presence of a 
supern ata n t de rived from un fi:act ion ated derma l cells cultured for 
48 h . T he spo ntan eo lls pro liferation tha t occurred as a result of 
macrophage d epletion (Fig 7, unfi'actionated DC fler .HlS CDllb-
DC) was essentially abrogated by supern atant fi-om unfi:actionated 
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F igure (,. Increased expansion and proliferation of pro-collagen 
type 1+ fibroblasts within macrophage-depleted (CDllb - ) cultured 
d e rmal cells. Macrophage-depleted (CD 'I I b - ) and undepicted (CDl I b ' ) 
de rmal ce ll s we re cultured fo r 7 d be fo re staining fo r D N A content 
(propidiulll iodide IPIl) and pro-collagen type I expression. r1) Mouse IgG 'l 
isot)'pc contro l lo r CDll b - dermal cells. C ultured CD1'1 b d ermal ce ll s 
(B) and unfractio na ted derma l cell s (C) were stained fo r pro-co llage n type 
[ (C). 
DC cultures (Fig 6 , CDlt b - D C plus unfi'actionated DC super-
na tant). T hese resul ts indicated that a so luble fa c tor is restric ting 
un fra ctiona ted dermal ce ll gro wth . Supe rnatant o btained fi'o m to tal 
dermal cell s wa s fra ctio nated b y centrifugation in Centricon 10 and 
30 chambers. Thymidine uptake by pro I.ife ratin g cells at 7 d of 
c ulture indicated that the MW of th e inhibito ry fa ctor is highe r than 
30 kDa (64 5 ::!:: 48 cpm with inhibito ry fi'a c tio n /lcrslIs 1311 9 :!:: 470 
cp m witho ut inhibitory frac tion). The relative percent inhibitory 
ac tivity o f each fi 'action was examin ed on C Dll b - dermal cell 
cul tures and found to be as fo ll o ws: 35'X, (O-lU kDa) , 67°1., (1 0 - 30 
kDa) and 9 5% (> 30 kDa) . Inhibito ry activ ity. based upo n antibo dy 
neutra lizatio n studi es. could no t be attributed to tumor necrosis 
facto r-a . transformin g gro w th fac to r-/31 , IL-l ra , interfe ro n-(\' . o r 
p late le t-deriv ed g rowth filc tor (data no t sho wn) . In additi o n no 
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F igure 7. Dermal cell spontaneous proliferat.ion r e straint v ia sol-
uble factors from dermal cells. Pro lifcr:! ciOIl of 1Il1fi'ncti onated dcrm :! 1 
cell s (101' ) and C DIlb- dermal ce ll s (/Il iddle). B o/( o/ll ) Proli fe ra tion of 
C D 'll b - dermal cclls cultured in the presence of supernata nt deri ved fi'o m 
a 48-h cul ture of ullfi'actionated dc rmal cell s. Derm al cell pro li ferntio n after 
7-d cul turc period was dc te nnill cd by l' l-Ij-T dR. upta ke fo r a period of 'I8 
h. Mean :!: SD of triplicilr.cs. 
reversal of growth inhibition occurred in in dom ethicin-treated 
unfi'actio lla ted dermal cell cultures (da ta n o t sho wn) . 
IL-10', IL-l{3, and IGF- l are Positive Regulatory Factors for 
Fibroblast Expansion It w as un likely th at exclu sively g rowth-
inhibito ry £, cto rs w ere pro duced in these unfi'actio nated primary 
cultures. To understand tibroblast g ro wth regulation in thi s sys te m. 
ne Lltral izing antibodies to IL-l a. IL-1,8. and IGF-l were used to 
identify positi ve gro wth-regula to ry fac tors associa ted w ith fibro-
blast expansion after rem oval of inhibito ry C OIl b + macrophages. 
T h c results indi cnted th at n emraliz in g an tibo dies to [L-l a reduced 
fibro bl ast prolife ratio n by 35'1.) compared w ith the IgG l isotype 
control (Fig 8) . N eutrali zati on of IL-l ,8 and IG F-l ea ch redu ced 
prolife ratio n by m ore than 90'1., (Fig 8) , howeve r. sugges tin g tha t 
the fibro blas t expansion observed afte r removal o f m acro phages is 
c riti -all y dependent mainl y upon IL-l/3 and lG F-l production by 
the rem aining cells . T hus, m acro phage inhibi tion is capable of 
do min ating the positi ve g rowth-pro m oting act ivities of IL- l a. 
IL-I /3 . and lGF-1 on prim ary dermal fi bro blas ts. 
DISC U SS IO N 
T he ability to prepare fresh ex IIi I/O pl;mary de rmal cell suspen sions 
now all ows precise identificatio n o f subsets using triple m arker fl o w 
cytometry and analys is o f diffe ren tial fun ction al ;Ic ti vities o f distinc t 
dermal cell subse ts. With thi s approach , we d escribe a novel 
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Figure 8. Fibroblas t expansion in CD11b- dermal c ell c ultures 
r e quire s IL-l{3 and I GF-l. D l1 b - d ermal cells were cul tl1I'ed in the 
prescn ce o fn eurraLi zing antibodies to IL- l (Y (4) . IL- I{3 (5). and IGF-l (6) or 
iso t)'pc co ntro l (3) , De rmal cell proli fe ration after 7-d cul ture peri od was 
dctermined by l' I-I I-TdR up take lor a period of 18 h . Mean :!: SD of 
tripli cates. 
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functio nal actIvity (fi bro blast gro wth res traint) of th e constitu tive 
derm al m acrophage po pul atio n . T he dermal macrophage subset is 
one of several dermal class II MHC I subse ts; these include cells of 
th e derm al Langerhans ce ll / dendritic anti gen presen ting cell lin-
eage (CD45 + COl a -, ,b -I- ,c + CDll b + ,c ,- FX lIla ") [4], no n- bo ne 
marrow-derived stromal celJs (C 0 45 - C Ol a - ,b - ,c - C01'1 b - ,c-
FX lIla" 1- ) [4], and macrophages (C045 + COla - ,b- ,c-
COlI b -I- ,c"- FX III" +1- ) (Fig 1, 2; [4]) . Among these class II MHC " 
demlal cell types, only the macrophage subset is capable of fibroblast 
growth restrain t; that is, removal of the C Ol -I- Langerhans cell-Like/ 
dendti tic APC popul atio n tailed to resul t in any degree o f increase in 
fi broblast proliferation, but removal of COl '1 b I c -, bone marrow-
del'ived cells resulted in unrestrained tt broblast pro liferation (despi te 
that the stromal class II MHC subset was in tact) . Conversely, the 
dermal Langerhans cell-Like/dendritic APC Lineage population is 
capable of potent APC activi ty, whereas the APC activity o f dermal 
macrophages and other class II MHC " demlal populations is either 
absent or at least 1000-fold less potent [4]. Thus, distinct reciprocal 
fun ctional activi ties can be MtJibuted to these n-vo distinct class II 
MI-IC + subsets within 1l01l11al human dennis. 
Fibroblast intera ctions wi th peripheral blood m ono nucl ea r ce ll s 
or monocytes have been prev io usly investigated using multiply 
passaged cultured fi bro bla sts [16 , :1 8,19,2 1,29,3 0]. Our data indi-
cate that mul tipl y passaged fibro bla st cul tures do no t mo del th e 
beha vio r o f fibro blas ts in o ur primary ex lIillO d ermal cell cultuxes; 
that is, the supe rn atant of CD 11 b -I- macro phage-containing de rmal 
ce ll s is not inhibito ry to multipl y passaged fibrobla st c ul ture 
pro Jjferati on (n o t shown) , al tho ug h th e same supem atant po tently 
inhibits COll b - derm al ce ll fibro bla st expansion (Fig 7) . T hese 
tindin gs underscore the impo rtan ce of m odeling ill I,h!() activities 
w ith ce lls that have not been heavily mo dulated by th e lack of 
signals present in th e ill "i" o miJieu. Simil arl y, it is completely 
unkn own wheth er m acro ph ages constitutive ly present in hum an 
papillary dermis are represen ted b y any mo nocytc subset present in 
periph eral blood . T he pe ripheral blood compartment con ta ins both 
COlI b '" and COt1 b - subsets [31], which lack C OlmoJecul es, but 
whi ch are heterogeneous wi th regard to C 0 36, C D"! c, COll a, and 
C01 4 expression [32] . O ur studies using fresh ex " il/o derm al cell 
suspensio ns to evalu ate tissue ma cropha ge intera ctio ns with fibro-
blasts thus represcnts a m o re direc t mo del o f the actual ill "i "o 
relatio nship in o rgans. 
Hum an derm al fibro bl asts and fibroblast-like dendrocytes and 
re lated m esench ymall y deri ved stromal cell s o f the de rmi s appear to 
ex hibit som e he terogene ity, but their ph enotypic identifi cation is 
poorl y deve lo ped . O ne maj o r fibrobl ast populatio n expresses th e 
epito pe detected by th e l B l 0 antibo dy. C om plement lys is o flBlO -I' 
fibrobl asts fro m hum an dermis concomi tantl y depleted of C 011b -l-
m3croph ages completely abrogated the pro lifera ti on that resul ts 
when such m acropha ges are removed . Fibrobla sts also appear 
heterogeneous with regard to their pro du ction of collagens [28) . 
Cell cycl e an alys is by Ro w cyto m etry o f the pro lite ratin g ce.lls in 
COltb - -cul tured de rmis showed tha t the prolifera tion was com-
pri sed by bo th a pro-collagen type r' fibrobl as t popul ation, as we ll 
as a pro-co llagen type 1- populatio n. Furthe r deve lopmen t o f the 
abili ty to distingui sh heterogeneo us subsets o f dermal fibro blasts 
based upon pa tterns of collagen biosynth esis and their responses to 
ho rm ones is needed to understand fully the ir reactivity to ma cro-
ph ages [28J. 
Unfo rtun ately, the identity of the negative gro wth regul atory 
ac tivi ty(s) released by dermal COllb+ macropha'ges could no t be 
identifi ed. T he material appears to be o f greater than 30 kDa in size, 
and not to be du e to pros tag landin E o r other cycl ooxyge nase 
produ cts . T he inhibi tio n was also not ne utralized by a vari e ty o f 
antibodies which bind active sites on cyto kin es previo usly identifi ed 
to have regul ato ry action on fi brobl asts, including interfero n-ty, 
transfo rming growth fac to r- (3 , and tUlllor necrosis fa ctor-a . T he 
growth inhibitory activity o f th e C Ollb + populatio n does appea r 
to be cyto lytic in nature and is apparent w ithin the first 24 b o f 
cul ture, as reveal ed by LOH release . However, whether the source 
of this material is ft.·o m viable o r dyin g CDll b -I- dermal cell s is no t 
T H E J OURNAL OF IN VESTIGATIV E D ERM ATO LOGY 
cl ear at thi s tim e sin ce bo th dead and live C OIl b -I- dermal cell s are 
p resent in these cultures. 
Fibroblas t proliferation has been studied in the context of certain 
skin and lun g diseases . T he proliferatio n of fibroblasts and the 
deposition of large am o un ts o f colla gen (matrix) in conditions like 
scleroderma [23] and granul o matous lun g di sease [33], suggest a 
lack of cont ro l on fi broblast fun ction , possibl y initiated by tbe 
absence o f an inhibi to ry fac tor re leased by macrophages which 
afFects fi brobla st o utgrowth in our model. In scleroderma patients, 
blood mo no nuclear cell and m o nocyte/ macrophage cytokines ap-
pea r to afFect passaged t.bro blas t growth [23]. Abnorm al macro-
ph ages in conjunction wi th fibrobla st acti va tio n also appears to 
occur in psoriasis [3 4,35] , whi ch may in turn regulate keratinocyte 
expansio n [22]. That fibro blast pro liferation occurs in lesional 
psoria sis is supported by o ur findin g that FX IIIn -I- strom al dendro-
cytes (whi ch in cludes some collagen-producing ceIJs) undergo a 
marked increase in proliferatio n ill silll (a fter ill " i llo JH nrd 
inj ec tion) 136]. T he fact tha t a soluble macrophage factor is 
responsibl e fo r fibro blas t downregulati on under 110rmal conditions 
may be of pathophys io logica l signi fica nce . 
S lIpported ill pnn iI)' N IA MS Cmlll R O- I A R4"1 64201 , lit" N ntiOllnl A lopecill 
II renl(/ FCIlIllr/ntioll, lite Bllren ll ~r Velernlls A U;' irs O./liee oJ Rese"relt "lid Dec,e!· 
"p/l( elll, nlld NCI C(/ lleer Ceiller Core C rnlll # PJ O-CA 46592-04. 
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